(Q41622137)

5 October 2017

1 reference

title

Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis? (English)

1 reference

5 October 2017

0 references

R Hohlfeld

1

1 reference

5 October 2017

1 July 1996

1 reference

Multiple Sclerosis Journal

5 October 2017

1 reference

5 October 2017

1

1 reference

5 October 2017

6

1 reference

5 October 2017

376-378

1 reference

Cachectin: more than a tumor necrosis factor

5 October 2017

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

The biology of cachectin/TNF--a primary mediator of the host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

The pathophysiology of tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Tumor necrosis factor, other cytokines and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Tumor necrosis factor receptor-mediated signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Contenders in FasL/TNF death signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859600100619

10.1177/135245859600100619

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference

PubMed ID

9345421